Shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) have earned an average recommendation of "Buy" from the six analysts that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $109.00.
A number of equities analysts have commented on USPH shares. Barrington Research restated an "outperform" rating and issued a $98.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, July 1st. JPMorgan Chase & Co. reduced their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 19th. JMP Securities restated a "market outperform" rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Finally, Wall Street Zen upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th.
Check Out Our Latest Stock Report on USPH
U.S. Physical Therapy Price Performance
Shares of U.S. Physical Therapy stock traded up $1.47 during trading on Friday, hitting $82.14. 158,966 shares of the company's stock traded hands, compared to its average volume of 121,404. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.17 and a quick ratio of 1.17. The firm's fifty day moving average price is $76.11 and its 200 day moving average price is $79.49. U.S. Physical Therapy has a twelve month low of $62.77 and a twelve month high of $101.20. The company has a market cap of $1.25 billion, a PE ratio of 37.68, a PEG ratio of 3.98 and a beta of 1.44.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.02. The business had revenue of $183.79 million for the quarter, compared to analyst estimates of $176.78 million. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The firm's revenue was up 18.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.51 EPS. Analysts forecast that U.S. Physical Therapy will post 2.67 earnings per share for the current year.
U.S. Physical Therapy Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 23rd were paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date of this dividend was Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio is presently 82.57%.
Insider Buying and Selling at U.S. Physical Therapy
In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of the business's stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the transaction, the director directly owned 2,594 shares of the company's stock, valued at approximately $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 2.00% of the company's stock.
Hedge Funds Weigh In On U.S. Physical Therapy
A number of institutional investors have recently modified their holdings of the stock. CBIZ Investment Advisory Services LLC raised its stake in shares of U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after buying an additional 122 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of U.S. Physical Therapy by 952.4% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company's stock worth $32,000 after buying an additional 400 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of U.S. Physical Therapy during the fourth quarter worth approximately $39,000. Fifth Third Bancorp raised its stake in shares of U.S. Physical Therapy by 34.6% during the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock worth $75,000 after buying an additional 265 shares during the last quarter. Finally, Lazard Asset Management LLC bought a new stake in shares of U.S. Physical Therapy during the fourth quarter worth approximately $84,000.
About U.S. Physical Therapy
(
Get Free ReportU.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading

Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.